Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Dermatological Treatment
|
January 25, 2011
Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study
Shilpa Gattu, Kristine Busse, Tina Bhutani, et al.
Cognitive Behaviour Therapy
|
June 4, 2025
Ethical considerations and practical suggestions for CBT consultation in mental health implementation research and practice
Samantha J Rushworth, Siena K Tugendrajch, Torrey A Creed, et al.
JMIR Mental Health
|
November 3, 2023
Freely Available Training Videos for Suicide Prevention: Scoping Review
Katherine Wislocki, Shari Jager-Hyman, Megan Brady, et al.
Inflammatory Bowel Diseases
|
July 11, 2022
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells
Anna Schweda, Emily Becker, Maximilian Wiendl, et al.
Journal of Visualized Experiments : Jove
|
October 9, 2018
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Emily Becker, Sebastian Schramm, Marie-Theres Binder, et al.
The Journal of Biological Chemistry
|
January 6, 2018
The NLR family pyrin domain-containing 11 protein contributes to the regulation of inflammatory signaling
Kornelia Ellwanger, Emily Becker, Ioannis Kienes, et al.
Frontiers in Immunology
|
May 7, 2021
Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19
Tanja M Müller, Emily Becker, Maximilian Wiendl, et al.
Clinical and Translational Gastroenterology
|
May 16, 2022
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Emily Becker, Anna Schweda, Karen A-M Ullrich, et al.
The British Journal of Dermatology
|
July 30, 2025
Efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial
Amy S Paller, Loretta Fiorillo, Emily Becker, et al.
Journal of Crohn'S & Colitis
|
August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation
Katharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Dermatological Treatment
|
January 25, 2011
Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study
Shilpa Gattu, Kristine Busse, Tina Bhutani, et al.
Cognitive Behaviour Therapy
|
June 4, 2025
Ethical considerations and practical suggestions for CBT consultation in mental health implementation research and practice
Samantha J Rushworth, Siena K Tugendrajch, Torrey A Creed, et al.
JMIR Mental Health
|
November 3, 2023
Freely Available Training Videos for Suicide Prevention: Scoping Review
Katherine Wislocki, Shari Jager-Hyman, Megan Brady, et al.
Inflammatory Bowel Diseases
|
July 11, 2022
Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells
Anna Schweda, Emily Becker, Maximilian Wiendl, et al.
Journal of Visualized Experiments : Jove
|
October 9, 2018
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Emily Becker, Sebastian Schramm, Marie-Theres Binder, et al.
The Journal of Biological Chemistry
|
January 6, 2018
The NLR family pyrin domain-containing 11 protein contributes to the regulation of inflammatory signaling
Kornelia Ellwanger, Emily Becker, Ioannis Kienes, et al.
Frontiers in Immunology
|
May 7, 2021
Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19
Tanja M Müller, Emily Becker, Maximilian Wiendl, et al.
Clinical and Translational Gastroenterology
|
May 16, 2022
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Emily Becker, Anna Schweda, Karen A-M Ullrich, et al.
The British Journal of Dermatology
|
July 30, 2025
Efficacy and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial
Amy S Paller, Loretta Fiorillo, Emily Becker, et al.
Journal of Crohn'S & Colitis
|
August 19, 2020
The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation
Katharina Gerlach, Kristina Lechner, Vanessa Popp, et al.
Page
of 5